Early response to preventive strategies in the diabetes prevention program

Journal of General Internal Medicine

Volumn 28, Issue 12, 2013, Pages 1629-1636

  Maruthur, Nisa M ^a,b   Ma, Yong ^c   Delahanty, Linda M ^d   Nelson, Julie A ^e   Aroda, Vanita ^f   White, Neil H ^g   Marrero, David ^h,i   Brancati, Frederick L ^a,b,j   Clark, Jeanne M ^a,b,j  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h REGENSTRIEF INSTITUTE   (United States)

ⁱ INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

diabetes prevention; diabetes risk; type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; METFORMIN; PLACEBO;

ADULT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; HYPERGLYCEMIA; LIFESTYLE MODIFICATION; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PREDIABETIC STATE; PRIMARY PREVENTION; RISK FACTORS; RISK REDUCTION BEHAVIOR; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84890432345     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-013-2548-4     Document Type: Article

References (16)

1. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
2. Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677-86. Epub 2009/11/03.
3. Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29(9):2102-7. Epub 2006/08/29.
4. Lachin JM, Christophi CA, Edelstein SL, et al. Factors associated with diabetes onset during metformin versus placebo therapy in the Diabetes Prevention Program. Diabetes. 2007;56(4):1153-9. Epub 2007/03/31.
5. Standards of medical care in diabetes - 2012. Diabetes Care. 2012;35(Suppl 1):S11-63. Epub 2012/01/04.
6. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care. 1999;22(4):623-34. Epub 1999/04/06.
7. American Diabetes Association. Standards of medical care in diabetes - 2011. Diabetes Care. 2011;34(Supplement 1):S11-61.
8. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20(7):1183-97. Epub 1997/07/01.
9. Lin D, Wei L. The robust inference for the cox proportional hazards model. J Am Stat Assoc. 1989;1074-78.
10. Wing RR, Hamman RF, Bray GA, et al. Achieving weight and activity goals among Diabetes Prevention Program lifestyle participants. Obes Res. 2004;12(9):1426-34. Epub 2004/10/16.
11. Svetkey LP, Stevens VJ, Brantley PJ, et al. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA. 2008;299(10):1139-48.
12. Sarwer DB, von Sydow Green A, Vetter ML, Wadden TA. Behavior therapy for obesity: where are we now? Curr Opin Endocrinol Diabetes Obes. 2009;16(5):347-52. Epub 2009/07/23.
13. Perreault L, Kahn SE, Christophi CA, Knowler WC, Hamman RF. Regression from pre-diabetes to normal glucose regulation in the Diabetes Prevention Program. Diabetes Care. 2009;32(9):1583-8. Epub 2009/07/10.
14. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343-50.
15. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(Journal Article):537-44.
16. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289-97. Epub 2006/01/05.